AAPL   314.56 (-0.69%)
MSFT   178.23 (-1.84%)
FB   224.22 (-3.44%)
GOOGL   1,402.48 (-1.33%)
AMZN   2,360.79 (-2.52%)
NVDA   327.19 (-6.17%)
BABA   199.02 (-1.34%)
GE   7.28 (+7.06%)
AMD   50.14 (-5.75%)
T   31.82 (+3.25%)
F   6.01 (+2.91%)
GILD   73.42 (+0.33%)
DIS   120.92 (-0.02%)
NFLX   403.50 (-2.72%)
BAC   25.40 (+4.57%)
BA   145.48 (+0.52%)
AAPL   314.56 (-0.69%)
MSFT   178.23 (-1.84%)
FB   224.22 (-3.44%)
GOOGL   1,402.48 (-1.33%)
AMZN   2,360.79 (-2.52%)
NVDA   327.19 (-6.17%)
BABA   199.02 (-1.34%)
GE   7.28 (+7.06%)
AMD   50.14 (-5.75%)
T   31.82 (+3.25%)
F   6.01 (+2.91%)
GILD   73.42 (+0.33%)
DIS   120.92 (-0.02%)
NFLX   403.50 (-2.72%)
BAC   25.40 (+4.57%)
BA   145.48 (+0.52%)
AAPL   314.56 (-0.69%)
MSFT   178.23 (-1.84%)
FB   224.22 (-3.44%)
GOOGL   1,402.48 (-1.33%)
AMZN   2,360.79 (-2.52%)
NVDA   327.19 (-6.17%)
BABA   199.02 (-1.34%)
GE   7.28 (+7.06%)
AMD   50.14 (-5.75%)
T   31.82 (+3.25%)
F   6.01 (+2.91%)
GILD   73.42 (+0.33%)
DIS   120.92 (-0.02%)
NFLX   403.50 (-2.72%)
BAC   25.40 (+4.57%)
BA   145.48 (+0.52%)
AAPL   314.56 (-0.69%)
MSFT   178.23 (-1.84%)
FB   224.22 (-3.44%)
GOOGL   1,402.48 (-1.33%)
AMZN   2,360.79 (-2.52%)
NVDA   327.19 (-6.17%)
BABA   199.02 (-1.34%)
GE   7.28 (+7.06%)
AMD   50.14 (-5.75%)
T   31.82 (+3.25%)
F   6.01 (+2.91%)
GILD   73.42 (+0.33%)
DIS   120.92 (-0.02%)
NFLX   403.50 (-2.72%)
BAC   25.40 (+4.57%)
BA   145.48 (+0.52%)
Log in

NASDAQ:ACRXAcelRx Pharmaceuticals SEC Filings & 10K Form

$1.56
-0.08 (-4.57 %)
(As of 05/27/2020 11:48 AM ET)
Add
Compare
Today's Range
$1.47
Now: $1.57
$1.70
50-Day Range
$1.05
MA: $1.43
$1.69
52-Week Range
$0.70
Now: $1.57
$3.02
Volume40,998 shs
Average Volume1.08 million shs
Market Capitalization$126.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

SEC Filings

AcelRx Pharmaceuticals (NASDAQ:ACRX) SEC Filings

DateFilerForm TypeView
05/27/2020
8:29 AM
AcelRx Pharmaceuticals (Subject)
TETRAPHASE PHARMACEUTICALS INC (Filed by)
Form 425
05/22/2020
3:11 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
3:10 PM
AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form 425
04/30/2020
7:24 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2020
7:22 AM
AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form 425
04/26/2020
11:15 PM
AcelRx Pharmaceuticals (Filer)
Form EFFECT
04/24/2020
5:09 AM
AcelRx Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
5:07 AM
AcelRx Pharmaceuticals (Filer)
Form DEF 14A
04/17/2020
3:52 PM
AcelRx Pharmaceuticals (Filer)
Form 10-K/A
04/08/2020
3:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
4:24 PM
AcelRx Pharmaceuticals (Filer)
Form S-4
Registration statement under Securities Act of 1933  
03/25/2020
3:01 PM
AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form 425
03/16/2020
2:57 PM
AcelRx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/16/2020
2:24 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
2:22 PM
AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form 425
03/16/2020
6:40 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
8:13 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:12 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:10 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:09 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:08 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:06 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
5:07 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:26 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
5:07 AM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:05 AM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:05 AM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:05 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:04 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2019
3:52 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:10 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
6:05 PM
AcelRx Pharmaceuticals (Issuer)
WAN MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:04 PM
AcelRx Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:03 PM
AcelRx Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:02 PM
AcelRx Pharmaceuticals (Issuer)
Afable Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:00 PM
AcelRx Pharmaceuticals (Issuer)
ADAMS ADRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
5:58 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:49 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
5:02 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:10 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
5:08 AM
AcelRx Pharmaceuticals (Filer)
Form DEFA14A
05/14/2019
5:03 AM
AcelRx Pharmaceuticals (Filer)
Form DEF 14A
05/09/2019
7:55 AM
AcelRx Pharmaceuticals (Filer)
Form 424B5
05/09/2019
7:52 AM
AcelRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:04 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
4:03 PM
AcelRx Pharmaceuticals (Filer)
Form PRE 14A
04/30/2019
5:20 AM
AcelRx Pharmaceuticals (Filer)
Form 10-K/A
03/12/2019
1:15 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
4:29 PM
AcelRx Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2019
4:25 PM
AcelRx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2019
3:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:28 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
3:26 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:45 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:44 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:43 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:42 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:40 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
4:33 PM
AcelRx Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/11/2019
3:31 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
11:05 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
11:04 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
6:31 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:13 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
5:35 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
4:18 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
4:16 PM
AcelRx Pharmaceuticals (Filer)
Form 424B5
11/13/2018
12:53 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
6:06 AM
AcelRx Pharmaceuticals (Filer)
Form 424B5
11/05/2018
4:29 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
4:24 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
4:23 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
4:21 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
3:50 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
8:23 AM
AcelRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2018
3:14 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
2:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
3:30 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2018
3:29 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
4:54 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:08 AM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
3:36 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
4:38 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
4:23 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
4:19 PM
AcelRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2018
3:18 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2018
3:16 PM
AcelRx Pharmaceuticals (Filer)
Form 424B5
07/02/2018
3:51 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
5:19 PM
AcelRx Pharmaceuticals (Issuer)
ADAMS ADRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
5:18 PM
AcelRx Pharmaceuticals (Issuer)
Afable Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
5:16 PM
AcelRx Pharmaceuticals (Issuer)
HOFFMAN C STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
5:14 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
5:13 PM
AcelRx Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
5:12 PM
AcelRx Pharmaceuticals (Issuer)
WAN MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
4:52 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
10:17 AM
AcelRx Pharmaceuticals (Subject)
LEERINK REVELATION HEALTHCARE FUND I, L.P. (Filed by)
Form SC 13G
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.